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Background: The root of Angelica sinensis (AS), also known as “Dang-gui,” was a popular herbal medicine widely
used in the treatment of gynecological diseases in China, Korea, and Japan for a long time. This study aimed to
determine the effects of ethyl acetate fraction from Angelica sinensis (EAAS) on the interleukin-1β (IL-1β)-induced
proliferation of rheumatoid arthritis synovial fibroblasts (RASFs), and production of matrix metalloproteinases
(MMPs), cyclooxygenase (COX) 2, and prostaglandin E2 (PGE2), involved in articular bone and cartilage destruction,
by RASFs.
Results: RASF proliferation was evaluated with cholecystokinin octapeptide (CCK-8) reagent in the presence of
IL-1β with/without EAAS. Expression of MMPs, tissue inhibitor of metalloproteinases-1 (TIMP-1), COXs, PGE2, and
intracellular mitogen-activated protein kinase (MAPK) signaling molecules, including p-ERK, p-p38, p-JNK, and NF-κB,
were examined using immunoblotting or semi-quantitative reverse transcription-polymerase chain reaction and
enzyme-linked immunosorbent assay. EAAS inhibited IL-1β-induced RASF proliferation; MMP-1, MMP-3, and COX-2
mRNA and protein expressions; and PGE2 production. EAAS also inhibits the phosphorylation of ERK-1/2, p38, and
JNK, and activation of NF-κB by IL-1β.
Conclusion: EAAS might be a new therapeutic modality for rheumatoid arthritis management.
Keywords: Angelica sinensis, COX, IL-1β, MMPs, Rheumatoid arthritis (RA)Background
Rheumatoid arthritis (RA) is a chronic inflammatory dis-
ease characterized by robust infiltration of leukocytes
into the synovium, resulting in hyperplasia of the syn-
ovial lining, progressive cartilage destruction, and finally,
erosion of the underlying bone [1]. Synovial fibroblasts
mediate joint destruction in RA by producing inflamma-
tory mediators such as cytokines, matrix metalloprotein-
ases (MMPs), and cyclooxygenase (COX)-2 that facilitate
the expansion and invasion of synovial fibroblasts into
the adjacent tissue. The regulation of these events has* Correspondence: ywhim@jbnu.ac.kr
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unless otherwise stated.been a primary target of therapeutic intervention in RA
[2]. Interleukin 1β (IL-1β) is considered the most import-
ant cytokine in the pathogenic process of inflammation in
RA; it induces proliferation of rheumatoid arthritis syn-
ovial fibroblasts (RASFs), and production of high levels of
MMPs and prostaglandin E2 (PGE2) via COX expression
by RASFs [3].
The root of Angelica sinensis (Oliv.) Diels (Apiaceae)
(AS), also known as “Dang-gui,” was a popular herbal
medicine widely used in the treatment of gynecological
diseases in China, Korea, and Japan for a long time.
Chemical and pharmacological studies of various ex-
tracts or compounds obtained from this herb were found
to increase myocardial blood flow, reduce radiation
damages [4-6]. It was also demonstrated as mainly con-
sisting of polysaccharides and having a protective effect. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cently, the ethyl acetate extract of AS (EAAS) showed
higher inhibitory activity of NF-κB transactivation than
hexane or water fractions [9]. However, no study has in-
vestigated the effects of EAAS on inflammatory reac-
tions, including proliferation of RASFs and production
of PGE2 by RASFs, which play a crucial role in the
pathogenesis of synovitis in RA.
The present study was undertaken to study the effects
of EAAS on IL-1β-induced production of proinflamma-
tory mediators by RASFs. MMPs, PGE2 and COX-2 were
studied and intracellular signaling factors were evaluated
to identify the mechanisms of the effects of EAAS. Here
we showed that EAAS can inhibit IL-1β-induced prolifera-
tion and inflammatory reactions via mitogen activated
protein kinase (MAPK)/nuclear factor-κB (NF-κB) path-
ways in RASFs.
Results
EAAS inhibits IL-1β-induced proliferation of RASFs
To evaluate the effect of EAAS on the growth properties
of RASFs, we initially measured cell proliferation with
IL-1β for 3 days. IL-1β is well known as a potent
growth-promoting factor for RASFs. Cell proliferation
was assayed as described in Materials and Methods. As
shown in Figure 1a, IL-1β accelerated the proliferation
of RASFs dose-dependently (from 0.1 to 10 ng/mL) over
time. To know the effect of EAAS on IL-1β-induced
proliferation of RASFs, EAAS (100 μg/mL) was added to
the RASFs cultures with/without IL-1β (1.0 ng/mL) for
2 days, and cholecystokinin octapeptide (CCK-8) assay
was performed. As shown in Figure 1b, the increase in
RASF proliferation was significantly greater in the cul-
ture with IL-1β than that in the control without IL-1β
and EAAS (p < 0.05). In Figure 1c, to ascertain the dose-
dependent effect of EAAS on IL-1β-induced prolifera-
tion of RASFs, different doses of EAAS (20, 100, 200 μg/
mL) were added to the RASFs cultures with IL-1β
(1.0 ng/mL) for 2 days, and CCK-8 assay was performed.
Effect of EAAS on IL-1β-induced MMPs, TIMPs, and COX
mRNA expressions in RASFs
Real-time PCR was performed to evaluate the expressions
of MMP-1, MMP-3, Tissue inhibitor of metalloproteinase
(TIMP)-1, and TIMP-2 mRNA in the monocultured
RASFs. RASFs were stimulated with IL-1β (1.0 ng/ml)
for 48 hours in the presence or absence of EAAS
(100 μg/mL). IL-1β enhanced the expression of MMP-1
and MMP-3 mRNA in RASFs (p < 0.05), but not of
TIMP-1 and TIMP-2 mRNA. EAAS inhibited the effects
of IL-1β on the expression of MMP-1 and MMP-3
mRNA (p < 0.05 and p < 0.01, Figure 2). IL-1β also enhanced
the expression of COX-2 mRNA in RASFs (p < 0.01),
but not of COX-1 (data not shown). EAAS inhibitedIL-1β-induced expression of COX-2 mRNA (p < 0.05,
Figure 2).Effect of EAAS on IL-1β-induced MMPs, TIMPs, and COX
protein expressions in RASFs
To further evaluate the expressions of MMPs, TIMPs,
and COX proteins in mono-cultured RASFs, we per-
formed Western blotting. RASFs were stimulated with
IL-1β (1.0 ng/mL) for 48 hours in the presence or
absence of EAAS (100 μg/mL). IL-1β enhanced the ex-
pressions of MMP-1 and MMP-3 proteins in RASFs
(p < 0.05), but not of TIMP-1 and TIMP-2 proteins, con-
sistent with the results of mRNA expression (Figure 3).
EAAS inhibited IL-1β-induced expressions of MMP-1
and MMP-3 proteins (p < 0.05,). IL-1β also enhanced
the expression of COX-2 protein in RASFs (p < 0.01),
but not of COX-1 (data not shown). EAAS inhibited IL-
1β-induced expression of COX-2 protein (p < 0.05).
EAAS also significantly decreased expressions of MMP-
1, MMP-3, and COX-2 proteins compared to those in
the dimethyl sulfoxide (DMSO) control condition with-
out IL-1β and EAAS (p < 0.05).EAAS inhibits IL-1β-induced PGE2 production in RASFs
To confirm the effect of EAAS on the role of IL-1β in
PGE2 production by RASFs, we examined the concen-
tration of PGE2 in the culture supernatant. RASFs (1 ×
104 cells) were grown in 25 cm2 tissue-culture flasks for
48 hours before and after treatment with IL-1β (1.0 ng/
mL) and/or EAAS (100 μg/mL). PGE2 production was
increased after IL-1β treatment (p < 0.05) in comparison
to the control, and it was significantly inhibited by treat-
ment with EAAS at 48 hours, as was expected with the
results of COX-2 expression (Figure 4).Effect of EAAS on IL-1β-induced signal pathways in RASFs
To demonstrate the involvement of the signal transduc-
tion and the mechanisms of the effects of EAAS on IL-
1β-induced RASFs proliferation, MMPs and COX-2 ex-
pression, and PGE2 production, activation of MAPKs
and NF-κB were evaluated in the RASFs. IL-1β activated
the intracellular MAPKs, including extracellular signal-
regulated kinase (ERK), p-38, and c-Jun N-terminal
kinases (JNK), and EAAS significantly inhibited the IL-
1β-induced intracellular MAPKs activation (Figure 5a).
Activation of NF-κB and p65, and degradation of cyto-
plasmic IkBa was observed in RASFs treated with IL-1β.
These effects of IL-1β on NF-κB activation were abro-
gated by EAAS (Figure 5b). These results indicate that
EAAS might inhibit IL-1β-induced proliferation of
RASFs, expression of COX-2, and production of PGE2
via intracellular MAPKs and NF-κB pathways.
Figure 1 IL-1β increased the proliferation of RASFs dose-dependently and EAAS inhibits IL-1β-induced proliferation of RASFs. IL-1β
accelerated the proliferation of RASFs dose- and time-dependently (from 0.1 to 10 ng/mL). Results are presented as mean ± SD, n = 3. *p < 0.05
or †p < 0.01 versus day 0 (a). EAAS (100 μg/mL) significantly inhibited IL-1-induced proliferation of RASFs after 2, 3 days culture (p < 0.05)
*p < 0.05 versus no IL-1β and EAAS, †p < 0.05 versus no IL-1β and EAAS, ‡p < 0.05 versus IL-1β without EAAS (b). EAAS inhibited IL-1β-induced
proliferation of RASFs dose-dependently. *p < 0.05 versus no IL-1β, †p < 0.05, ‡p < 0.01 versus IL-1β without EAAS (c).
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Since herbal medicines have become popular around the
world, pharmacological evidence to help understand the
action of these medicines and their underlying mecha-
nisms is needed. Recent therapeutic interest has focused
on AS’s cardiovascular, hepatoprotective, antioxidant,
and immunomodulatory properties. The active principleof AS has been found to include a number of anti-
inflammatory substances [10]. The main chemical con-
stituents of Angelica roots are ferulic acid, Z-ligustilide
(the main lipophilic component of the essential oil of
AS), angelicide, butylidenephthalide, and butylphthalide
[11]. Ferulic acid has been demonstrated to exhibit anti-
Alzheimer’s disease, antimicrobial, and anticarcinogenic
Figure 2 EAAS inhibited IL-1β-induced production of MMPs and COX-2 in RASFs. IL-1β enhanced the expression of MMP-1, MMP −3,
TIMP-1, and COX-2 protein compared with the results without IL-1β. EAAS inhibited the IL-1β-induced expression of MMP-1, MMP-3, and COX-2
protein. Results are presented as mean ± SD. n = 3. *p < 0.05 versus no IL-1β and EAAS, †p < 0.05 versus no IL-1β and EAAS, ‡p < 0.05 versus
IL-1β without EAAS.
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in the EAAS were calculated as 3.74 and 15.95 mg/g dry
weight of the whole plant, respectively [9]. This compo-
nent of EAAS also showed higher inhibitory activity of
NF-κB transactivation than hexane or water fractions
[9]. Furthermore, EAAS inhibits the production of
inflammatory mediators alleviates acute inflammatory
hazards and protect mice from endotoxic shock [12].
However, the exact components of AS that are involved
in anti-inflammatory effects in RASFs are not yet known.
Furthermore, there were no reports on the effects of
EAAS on the inflammatory reactions, including produc-
tion of MMPs, COX-2, and PGE2 by RASFs and the
mechanisms, which play a crucial role in the pathogenesis
of synovitis and articular destruction in RA. We showed
here that EAAS inhibits IL-1β-induced cell proliferation,
COX-2 expression, and PGE2 production in RASFs by in-
hibition of activation of the MAP kinases ERK1/2, p-38,
and JNK, and NF-κB signaling pathways. These findingsFigure 3 The protein were extracted from RASFs and analyzed by We
TIMP-1, and COX-2 protein compared with the results without IL-1β. EAAS
protein. Results are presented as mean ± SD. n = 3. *p < 0.05 versus no IL-1
IL-1β without EAAS.suggest that EAAS can be used as a new therapeutic agent
for management of RA by decreasing inflammation.
The hyperplasia of synovial fibroblasts is one of the
most striking features of RA and is considered to be es-
sential for the evolution of joint destruction in RA [2].
The tumor-like proliferation of RASFs is considered to
be the major mechanism for the hyperplasic growth of
the RA synovium and eventual destruction of the articu-
lar bones and cartilage.3 IL-1β plays an important role
in the pathogenesis of inflammatory synovitis and joint
destruction in RA by inducing the proliferation of
fibroblast cell lines [13]. This study showed that EAAS
significantly inhibits IL-1β-induced proliferation of
RASFs in a dose- and time-dependent manner. This
probably means that EAAS would be an ideal treatment
for RA. However, further study is required to know the
effects of EAAS on RASF proliferation in the absence
or presence of stimulating factors and to define the
exact mechanism.stern blotting. IL-1β enhanced the expression of MMP-1, MMP −3,
inhibited the IL-1β-induced expression of MMP-1, MMP-3, and COX-2
β and EAAS, †p < 0.05 versus no IL-1β and EAAS, ‡p < 0.05 versus
Figure 4 PGE2 production was inhibited by treatment with
EAAS. IL-1 production of PGE2 by RASFs was evaluated with ELISA
kit. IL-1β-induced PGE2 production was significantly inhibited by
EAAS. Results are presented as mean ± SD. n = 3. *p < 0.05 versus
no IL-1β and EAAS, ‡p < 0.05 versus IL-1β without EAAS.
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are expressed by human RASFs and that the expression
of COX-2 is enhanced by proinflammatory cytokines,
such as IL-1β [14]. COX-2 converts free arachidonic
acid into prostaglandins, including a variety of bioactive
products (PGI2, thromboxane A2 (TXA2), PGE2, and
PGD2). PGE2, a pleiotropic mediator of inflammation,
provides certain homeostatic functions, but its excessive
production in the joints of RA patients is associated withFigure 5 Effects of EAAS on IL-1β-induced MAPK signal pathways and
ERK, p38, and JNK and EAAS inhibited the IL-1β-induced activation of p38
IkBα and EAAS inhibited the IL-1β-induced activation of NF-kB (b). Results a
‡p < 0.05 versus IL-1β without EAAS.many pathologic processes, and plays a critical role in
eliciting the signs and symptoms of inflammation [15].
This study found that EAAS inhibits both IL-1β-induced
COX-2 protein expression and PGE2 synthesis dose-
dependently over time. Thus, further studies are also
needed to identify the EAAS components that are re-
sponsible for the results of our study. It is also necessary
to demonstrate the above effects on inflammatory joint
disease with in vivo systems, such as animal models of
RA and collagen-induced arthritis (CIA).
NF-κB and MAPKs participate in inflammation and
destruction of joints in RA. It is known that inactive NF-
κB normally binds to IkB in the cytosol, and NF-κB can
be activated by proinflammatory cytokines, IL-1β and
TNF-α [16]. JNK, p38, and ERK are expressed in cul-
tured RASFs and are readily activated by IL-1β [17].
Prostaglandins have also been described as being under
the influence of p38 MAPK [18]. This has been con-
firmed in a study in which it was reported that glucocor-
ticoids destabilize COX-2 mRNA by inhibiting the p38
MAPK route [19]. Numerous studies have demonstrated
that inhibitors of MAPKs or NF-κB decrease synovial in-
flammation, bone destruction, and cartilage damage in
animal models of arthritis, including adjuvant arthritis in
rats and CIA in mice [20]. To identify the mechanisms
of the effects of EAAS on IL-1β-induced proliferation of
RASFs, expression of COX-2, and production of PGE2,NF-kB activation in RASFs. IL-1β enhanced the phosphorylation of
and JNK (a). IL-1β activated nuclear NF-kB and decreased cytoplasmic
re presented as mean ± SD. n = 3. *p < 0.01 versus no IL-1β and EAAS,
Lee et al. Biological Research 2014, 47:41 Page 6 of 8
http://www.biolres.com/content/47/1/41the activation of the MAPKs and NF-κB was examined.
This study showed that EAAS inhibits the IL-1β-
induced activation of NF-κB and phosphorylation of
ERK, p38, and JNK. However, further studies are needed
to identify the very important EAAS components and
the mechanism by which EAAS inhibits the effects of
IL-1β on RASFs. Further investigation is also needed to
discern how EAAS suppresses NF-κB activation, and to
identify the components of NF-κB that are suppressed
and the kind of intracellular signaling factors specifically
or directly involved in the effect of EAAS on the prolif-
eration and PGE2 production in RASFs.
Conclusions
This is the first study to report that EAAS can inhibit
the IL-1β-induced proliferation of RASFs, expression of
COX-2, and production of PGE2. This study also
showed that EAAS inhibits the activation of NF-κB and
phosphorylation of MAPKs pathways. Taken together,
these findings suggest that EAAS may be useful in the
treatment of inflammatory diseases, including RA. How-
ever, further studies are required to identify the exact
mechanism underlying the inhibition of synovial cell
proliferation and inflammatory reactions, and to find the
active components in the EAAS.
Methods
Preparation of crude extract of Angelica sinensis
AS was collected from Jiri Mountain in South Korea and
plant material was identified by an authority at the
Rheumatology Laboratory and Research Center for Pul-
monary Diseases, Chonbuk National University Medical
School, Jeonju, Jeonbuk, South Korea. In total, 10 g of
AS was extracted with 300 ml of 95% ethanol at 50°C
for 3 hours twice. The total crude extract was evapo-
rated under vacuum to yield a residue, and then the
residue was suspended in 90% ethanol and successively
partitioned with hexane, benzene, trichloromethane, ethyl
acetate, n-butanol and water fractions, consecutively as
described [21]. The ethyl acetate fraction was used in this
study after well drying the fraction. And we used kaemp-
ferol 0.852 ug and decursin 2.116 ug in 1 mg/mL of ex-
tract by quantifying the content.
Reagents and antibodies
Recombinant human IL-1β was purchased from R&D
system (Minneapolis, Minnesota, USA). Monoclonal
antibody (mAb) against MMP-1, MMP-3, tissue inhibi-
tor of metalloproteinase (TIMP), and COX-2 was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). mAb against extracellular signal-regulated kinase
(ERK), phosphorylated ERK (p-ERK), C-jun N-terminal
kinase (JNK), phosphorylated JNK (p-JNK), p38, p-p38,
nuclear factor κB (NF-κB) (p65), nuclear factor of kappalight polypeptide gene enhancer in B-cells inhibitor,
alpha (IκBα) and β-actin were purchased from Cell Sig-
naling (Beverly, MD, USA). Fetal bovine serum (FBS)
was obtained from Gibco BRL (Life Technologies, Grand
Island, NY, USA).
Isolation and culture of RASFs
Synovial tissues obtained at the time of total knee arthro-
plasty in patients who fulfilled the American College
of Rheumatology Criteria for RA [22], as previously de-
scribed [23]. Synovial fibroblasts from passages 3–7 were
used for each experiment and were morphologically
homogeneous and had the appearance of RASFs with typ-
ical fibroblastoid configuration under inverse microscopy.
The purity of the cells was tested by flow cytometry using
phycoerythrin (PE)-conjugated anti-Thy-1 (CD90) or anti-
CD14 and fluorescein isothiocyanate (FITC)-conjugated
anti-CD3 mAb (BD Pharmingen, San Diego, CA). In-
formed consent was obtained from all patients, and the
study protocol was approved by the Chonbuk National
University Hospital Ethical Committee.
RNA Isolation and semiquantitative RT-PCR of COX, MMPs
and TIMP
Total RNA was extracted from cultured cells using the
TRIsol reagent (Invitrogen, Carlsbad, CA, USA) follow-
ing the manufacturer’s instructions. One microgram of
RNA was reverse-transcribed using Maxime RT Premix
Kit (iNtRON Biotechnology, Korea). cDNA was amplified
using the following primer sets: COX-1 (sense) 5′-GCT
ATT CCG GCC CCA ACT-3′ (antisense) 5′-GAT GAA
GGT GGC ATT GAC AAA CT-3′, COX-2 (sense) 5′-
TCC TTG CTG TTC CCA CCC ATG-3′ (antisense) 5′-
CAT CAT CAG ACC AGG CAC CAG-3′, MMP-1
(sense) 5′-GAA GGA GAT GAA GCA GCC CAG ATG
T-3′ (antisense) 5′-CAG TTG TGG CCA GAA AAC
AGA AGT GAA A-3′, MMP-3 (sense) 5′GAC ACC AGC
ATG AAC CTT GTT-3′ (antisense) 5′-GGA ACC GAG
TCA GGA CTA TG-3′, TIMP-1 (sense) 5′-CCT TCT
GCA ATT CCG ACC TCG TC-3′ (antisense) 5′-CGG
GCA GGA TTC AGG CTA TCT GG-3′, glyceraldehyde
3-phosphate dehydrogenase (GAPDH) (sense) 5′-ACC
ACA GTC CAT GCC ATC AC-3′ (antisense) 5′-TCC
ACC ACC CTG TTG CTG TA-3′. PCR products were
electrophoresed by using 1% agarose gels and visualized
by staining with ethidium bromide. Densitometric ana-
lysis was performed on the relative intensity of each
band using the Multi Gauge program, version 3.0 (Fuji
film, Tokyo, Japan).
Cell viability analysis
Cell viability was determined by a cell counting kit-8
(CCK-8; Dojindo Laboratories, Japan) according to the
manufacturer’s instructions. Briefly, 2-(2-methoxy-4-
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tetrazolium (CCK-8) was reduced by dehydrogenases in
cells to yield an orange-colored product (formazan)
[24]. The amount of the formazan dye generated by de-
hydrogenases in cells was directly proportional to the
number of living cells. RASFs (1 × 105 cells per well in
complete RPMI-1640 media in a 96-well plate) were
cultured in 200 mL medium per well without antigen
stimulation in the presence or absence of 100 μg/mL
EAAS for 2 days. CCK-8 (20 mL) was added to each
well of the plate and the cells were incubated for 2–3
hours. The absorbance was measured at 450 nm using a
microplate reader.
Assay of PGE2 production
RASFs were grown in 25 cm2 tissue-culture flasks for
48 hours before treatment. After washing with PBS
(pH 7.4), cells were pretreated with IL-1β (1.0 ng/mL) or
EAAS (100 μg.mL) at 37°C for 48 hours in DMEM con-
taining 10% (v/v) FCS in an atmosphere of 5% CO2. The
culture supernatant described above was collected at
2 days. The level of PGE2 in the medium was deter-
mined by ELISA kit (R&D Systems) in accordance with
the instructions of the manufacturer.
Immunoblotting
RASFs (1 × 106 cells) were seeded on 100-mm culture
dishes and harvested in phosphate buffered saline (PBS)
after stimulation as described above. Cells were lysed in
lysis buffer containing 50 mM Tris-CL, 150 mM NaCl,
5 mM EDTA 1% Triton X-100, 1 mM sodium fluoride,
1 mM sodium vanadate, 1% deoxycholate, and protease
inhibitors. To determine the membrane COX-2 expres-
sion on RASFs, cell membranes were prepared from iso-
lated RASFs, as described previously [25]. To analyze
NF-kB (p65), nuclear extract was prepared using a previ-
ously described method [23]. To determine the cytoplas-
mic IkBa, cytoplasmic extracts were prepared from
isolated RASFs as described previously [23]. The protein
concentration was determined by the Bio-Rad protein
assay regent (Bio-Rad Laboratories, USA). Samples (50 mg)
were prepared with the four volume of 0.5 M Tris buffer
(pH 6.8) containing 4% SDS, 20% glycerol and 0.05%
bromophenol blue at 95°C for 5 min. SDS-PAGE was
performed in 10% slab gel. Proteins were transferred to
nitrocellulose paper. The membrane was washed in
blocking buffer (10 mM Tris–HCl pH 8.0, 150 mM
NaCl, 5% fat-free milk) for 60 min at room temperature
with shaking and then washed with TBST (TBS, 0.01%
Tween 20). Primary antibodies (10 mg/ml) against
MMP-1, −3, TIMP-1, −2, COX-1, −2, ERK, p-ERK-1/2,
p-38, p-p38 MAPK, JNK, p-JNK, NF-kB (p65), IkBa
and β-actin was incubated at 4°C for 4 hr. The second-
ary HRP-conjugated antibody was goat anti-mouse IgG(Stressgen Bioreagents, Ann Arbor, MI, USA). Reactive pro-
teins were detected using enhanced chemiluminescence
(ECL, Amersham Life Sciences, Arlington, IL, USA)
using Fuji film LAS-3000 (Tokyo, Japan).
Statistical analysis
All data were expressed as the mean ± SD of triplicates
and all data were analyzed by the SPSS 18.0 program.
Group mean values were compared by Student’s t test or
ANOVA as appropriate. The significance of difference
was defined as p values < 0.05, or p values < 0.01.
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